Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc EHA Data Review Conference Call Transcript

Jun 14, 2019 / 12:00PM GMT
Release Date Price: $18.62 (+0.54%)
Operator

Good day, ladies and gentlemen, and welcome to the Kura Oncology EHA data review conference call. (Operator Instructions) As a reminder, this conference may be recorded.

I would now like to turn the conference over to Dr. Troy Wilson, President and CEO of Kura Oncology. You may begin.

Troy Edward Wilson
Kura Oncology, Inc. - Chairman, CEO & President

Thank you, operator, and welcome, everyone, to our EHA data review. I'm Troy Wilson, Kura Oncology's President and CEO; and I'm here with Antonio Gualberto, our Head of Development and Chief Medical Officer; as well as Marc Grasso, our Chief Financial and Chief Business Officer.

We're going to be referring to certain slides that are available on our website at kuraoncology.com in the Corporate Presentation section. And in addition, the actual oral presentation that Dr. Foss will be presenting tomorrow, as well as the poster presentation, are available on the Scientific Publications section of our website should you choose to refer to them.

If we can go to the next slide, Slide #2,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot